HCR Wealth Advisors lessened its stake in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 7.4% during the 3rd quarter, Holdings Channel reports. The firm owned 6,552 shares of the financial services provider’s stock after selling 521 shares during the quarter. HCR Wealth Advisors’ holdings in iShares Nasdaq Biotechnology ETF were worth $729,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Benjamin F. Edwards & Company Inc. grew its stake in iShares Nasdaq Biotechnology ETF by 636.4% in the third quarter. Benjamin F. Edwards & Company Inc. now owns 891 shares of the financial services provider’s stock valued at $109,000 after purchasing an additional 770 shares during the last quarter. Schroder Investment Management Group purchased a new position in iShares Nasdaq Biotechnology ETF in the second quarter valued at about $105,000. Bay Colony Advisory Group Inc d b a Bay Colony Advisors purchased a new position in iShares Nasdaq Biotechnology ETF in the second quarter valued at about $134,000. KHP Capital LLC grew its stake in iShares Nasdaq Biotechnology ETF by 61.1% in the second quarter. KHP Capital LLC now owns 1,450 shares of the financial services provider’s stock valued at $159,000 after purchasing an additional 550 shares during the last quarter. Finally, Truvestments Capital LLC acquired a new stake in iShares Nasdaq Biotechnology ETF in the third quarter worth about $203,000. Institutional investors own 66.39% of the company’s stock.

Shares of NASDAQ IBB opened at $105.05 on Monday. iShares Nasdaq Biotechnology ETF has a fifty-two week low of $100.22 and a fifty-two week high of $122.97.

ILLEGAL ACTIVITY WARNING: “HCR Wealth Advisors Has $729,000 Holdings in iShares Nasdaq Biotechnology ETF (IBB)” was reported by Daily Political and is owned by of Daily Political. If you are accessing this report on another publication, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this report can be read at https://www.dailypolitical.com/2018/11/19/hcr-wealth-advisors-has-729000-holdings-in-ishares-nasdaq-biotechnology-etf-ibb.html.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Recommended Story: What is the balance sheet?

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.